|
|
Volumn 29, Issue 5, 2011, Pages 379-380
|
|
Sequencing firms eye pathology labs as next big market opportunity.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
X LINKED INHIBITOR OF APOPTOSIS;
BIOLOGY;
BIOTECHNOLOGY;
CHILD;
COMPUTER PROGRAM;
DNA SEQUENCE;
ECONOMICS;
GENETICS;
HUMAN;
INVESTMENT;
LABORATORY;
MALE;
METHODOLOGY;
MUTATION;
NOTE;
BIOLOGICAL MARKERS;
BIOTECHNOLOGY;
CHILD;
COMPUTATIONAL BIOLOGY;
HUMANS;
INVESTMENTS;
LABORATORIES;
MALE;
MUTATION;
SEQUENCE ANALYSIS, DNA;
SOFTWARE;
X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;
|
|
EID: 80052527896
PISSN: None
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0511-379 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|
